According to the trial’s chief investigator, Professor Christ Butler, targetting Covid at an early stage is most beneficial. He said: “It is early on in the illness, when people are still being cared for in the community, that treatments for COVID-19 could have their greatest benefit. “This new trial will test whether exciting, new antiviral […]